Clinical Trial Update: Extracorporeal Shockwave Therapy for the Treatment of Chronic Angina Pectoris [Phase 1]

View source ↗

Summary

Phase 1 trial of Extracorporeal Shockwave Therapy for refractory angina pectoris has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris

Snippet

Sponsor: Medispec | Conditions: Refractory Angina Pectoris | Phase 1 | Status: SUSPENDED